Amarin Corp Plc (AMRN)

[sts66]

The second I read the first link saying “Mineral Oil plays no role in the absorption of statins and changes in LDL-C nor in outcomes.” one of Nissen's complaints popped into my head - and I'm talking about it only took a split second for me to recall this - hs-CRP in the placebo group doubled - that was part of his proof that MO was interfering with statins, because they lower hs-CRP. AMRN claimed reversion to the mean I believe, I don't recall if the V group's levels went down or not, but I think not by a stat sig amount - rise in placebo group was definitely stat sig.

The EPADI doc is extremely well done (as usual, you guys rule), but it apparently didn't change the minds of the NICE committee - which makes me wonder something - is it possible there's and egotistical dominant member of that group that strongly believes MO affected R-IT results, and he's intimidating the other members into going along with him? Meaning they have a Nissen on their team? Don't forget the ACC/AHA still haven't put V on their CVD guidelines, saying the MO issue clouds R-IT results and a 2nd trial using a different placebo has to be run to confirm them.